Pharmeasy owned Thyrocare Technologies declared an interim dividend of ₹18 per share

26 July 2024

Pharmeasy-owned (66.1% stake)Thyrocare Technologies declared an interim dividend of ₹18 per share for financial 2022-23. The dividend yield comes to around 3.72% based on the current share price of Thyrocare Technologies.